» Articles » PMID: 23186527

Interferon-γ- and Glucocorticoid-mediated Pathways Synergize to Enhance Death of CD4(+) CD8(+) Thymocytes During Salmonella Enterica Serovar Typhimurium Infection

Overview
Journal Immunology
Date 2012 Nov 29
PMID 23186527
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Thymic atrophy is known to occur during infections; however, there is limited understanding of its causes and of the cross-talk between different pathways. This study investigates mechanisms involved in thymic atrophy during a model of oral infection by Salmonella enterica serovar Typhimurium (S. typhimurium). Significant death of CD4(+) CD8(+) thymocytes, but not of single-positive thymocytes or peripheral lymphocytes, is observed at later stages during infection with live, but not heat-killed, bacteria. The death of CD4(+) CD8(+) thymocytes is Fas-independent as shown by infection studies with lpr mice. However, apoptosis occurs with lowering of mitochondrial potential and higher caspase-3 activity. The amounts of cortisol, a glucocorticoid, and interferon-γ (IFN-γ), an inflammatory cytokine, increase upon infection. To investigate the functional roles of these molecules, studies were performed using Ifnγ(-/-) mice together with RU486, a glucocorticoid receptor antagonist. Treatment of C57BL/6 mice with RU486 does not affect colony-forming units (CFU), amounts of IFN-γ and mouse survival; however, there is partial rescue in thymocyte death. Upon infection, Ifnγ(-/-) mice display higher CFU and lower survival but more surviving thymocytes are recovered. However, there is no difference in cortisol amounts in C57BL/6 and Ifnγ(-/-) mice. Importantly, the number of CD4(+) CD8(+) thymocytes is significantly higher in Ifnγ(-/-) mice treated with RU486 along with lower caspase-3 activity and mitochondrial damage. Hence, endogenous glucocorticoid and IFN-γ-mediated pathways are parallel but synergize in an additive manner to induce death of CD4(+) CD8(+) thymocytes during S. typhimurium infection. The implications of this study for host responses during infection are discussed.

Citing Articles

Endogenous thymic regeneration: restoring T cell production following injury.

Granadier D, Acenas 2nd D, Dudakov J Nat Rev Immunol. 2025; .

PMID: 39762553 DOI: 10.1038/s41577-024-01119-0.


Induction of Thymus Atrophy and Disruption of Thymocyte Development by Fipronil through Dysregulation of IL-7-Associated Genes.

Kuo J, Wu H, Tung C, Huang W, Lin C, Wang C Chem Res Toxicol. 2024; 37(9):1488-1500.

PMID: 39141674 PMC: 11409377. DOI: 10.1021/acs.chemrestox.4c00060.


Primary and secondary defects of the thymus.

Dinges S, Amini K, Notarangelo L, Delmonte O Immunol Rev. 2024; 322(1):178-211.

PMID: 38228406 PMC: 10950553. DOI: 10.1111/imr.13306.


Thymus, undernutrition, and infection: Approaching cellular and molecular interactions.

Savino W, Duraes J, Maldonado-Galdeano C, Perdigon G, Mendes-da-Cruz D, Cuervo P Front Nutr. 2022; 9:948488.

PMID: 36225882 PMC: 9549110. DOI: 10.3389/fnut.2022.948488.


Bezlotoxumab prevents extraintestinal organ damage induced by infection.

Mileto S, Hutton M, Walton S, Das A, Ioannidis L, Ketagoda D Gut Microbes. 2022; 14(1):2117504.

PMID: 36045589 PMC: 9450906. DOI: 10.1080/19490976.2022.2117504.


References
1.
Lee J, Boechat M, Belzer M, Church J, De Ville J, Nielsen K . Thymic volume, T-cell populations, and parameters of thymopoiesis in adolescent and adult survivors of HIV infection acquired in infancy. AIDS. 2006; 20(5):667-74. DOI: 10.1097/01.aids.0000216366.46195.81. View

2.
Wang S, Huang K, Lin Y, Lei H . Sepsis-induced apoptosis of the thymocytes in mice. J Immunol. 1994; 152(10):5014-21. View

3.
Andrade C, Gameiro J, Nagib P, Carvalho B, Talaisys R, Costa F . Thymic alterations in Plasmodium berghei-infected mice. Cell Immunol. 2008; 253(1-2):1-4. DOI: 10.1016/j.cellimm.2008.06.001. View

4.
Lynch H, Goldberg G, Chidgey A, van den Brink M, Boyd R, Sempowski G . Thymic involution and immune reconstitution. Trends Immunol. 2009; 30(7):366-73. PMC: 2750859. DOI: 10.1016/j.it.2009.04.003. View

5.
Garrido C, Rallon N, Soriano V, Lopez M, Zahonero N, de Mendoza C . Mechanisms involved in CD4 cell gains in HIV-infected patients switched to raltegravir. AIDS. 2012; 26(5):551-7. DOI: 10.1097/QAD.0b013e3283509826. View